Form D — Qlaris Bio, Inc.

0001786717-26-000002 · filed Jun 17, 2026

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry: Biotechnology
Exemptions: 06b
Reported offering amount: $3,946,659
Reported amount sold: $3,946,659
Minimum investment: $0
Investors: 8
Sales commission: $0
Finders' fees: $0

Issuer

Name: Qlaris Bio, Inc.
CIK: 1786717
Entity: Corporation
Jurisdiction: DELAWARE
Year incorporated: —
Address: 770 Legacy Place
Dedham, MA 02026
Phone: 917-217-7007

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Frederic Guerard · Executive Officer

Dedham, MA Find on LinkedIn ↗
Andrew Danielson · Director

Rochester, MN Find on LinkedIn ↗
Adrienne Graves · Director

Dedham, MA Find on LinkedIn ↗
Ronald M. Hunt · Director

New York, NY Find on LinkedIn ↗
Wende Hutton · Director

Menlo Park, CA Find on LinkedIn ↗
Barbara Wirostko · Executive Officer

Dedham, MA Find on LinkedIn ↗
Robert Warner · Director

Southlake, TX Find on LinkedIn ↗

Other filings from this issuer

Form D — Nov 17, 2025 — 0001786717-25-000002

View the original filing on SEC EDGAR ↗